Cancer Genetics Renegotiates Credit Agreement with Wells Fargo | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics today announced a renegotiated credit agreement with Wells Fargo.

The agreement, entered into on April 1, provides Cancer Genetics with a maximum borrowing amount of $6 million, which was fully drawn as of April 1, it said in a document filed with the US Securities and Exchange Commission. The line was extended through April 1, 2016 at an interest rate of LIBOR plus 1.75 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.